Zwycięstwo! On June 17, 2024, Govenor Mckee signed H7625/S2255 into law. Rhode Island is only the second state to pass such a groundbreaking law.

RI H7625/S2255 prohibits insurers from imposing cost sharing (copays or meeting a deductible) or utilization review (also referred to as utilization management), such as prior authorization or step therapy, for any HIV prevention drug.

Dowiedz się więcej about PrEP and how GLAD is working to expand access to this game-changing HIV prevention medication.